SPRUCE BIOSCIENCES, INC. (SPRB) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-09

SPRUCE BIOSCIENCES, INC. (SPRB) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 3 Form 8-K material event filings were reported by SPRB in the last 90 days. InsiderAlpha tracks every SPRB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About SPRUCE BIOSCIENCES, INC. (SPRB)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001683553

90-Day SEC Filing Activity

Form 4 filings (90d)	6
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-07-09

Recent SPRB Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-30	Szwarcberg Javier B.	CHIEF EXECUTIVE OFFICER	A — Grant or award	266	$4.53	$1K	SEC
2025-10-06	Parkman Healthcare Partners LLC	10% Owner	S — Open-market sale	232	$19.33	$4K	SEC
2025-10-06	Parkman Healthcare Partners LLC	10% Owner	S — Open-market sale	25	$17.46	$436	SEC
2025-10-06	Parkman Healthcare Partners LLC	10% Owner	P — Open-market purchase	256	$17.91	$5K	SEC
2024-12-16	Gharib Samir M.	PRESIDENT AND CFO	F — Tax withholding / forfeiture	13.3K	$0.39	$5K	SEC
2024-12-16	Szwarcberg Javier B.	CHIEF EXECUTIVE OFFICER	M — Option exercise	89.7K	$0.00	—	SEC
2024-12-16	Szwarcberg Javier B.	CHIEF EXECUTIVE OFFICER	F — Tax withholding / forfeiture	32.0K	$0.39	$12K	SEC
2024-12-16	Szwarcberg Javier B.	CHIEF EXECUTIVE OFFICER	M — Option exercise	111.0K	$0.00	—	SEC
2024-12-16	Szwarcberg Javier B.	CHIEF EXECUTIVE OFFICER	F — Tax withholding / forfeiture	39.6K	$0.39	$15K	SEC
2024-12-16	Gharib Samir M.	PRESIDENT AND CFO	M — Option exercise	38.5K	$0.00	—	SEC
2024-12-16	Gharib Samir M.	PRESIDENT AND CFO	F — Tax withholding / forfeiture	13.7K	$0.39	$5K	SEC
2024-12-16	Charlton Ralph William III	CHIEF MEDICAL OFFICER	M — Option exercise	26.6K	$0.00	—	SEC
2024-12-16	Charlton Ralph William III	CHIEF MEDICAL OFFICER	F — Tax withholding / forfeiture	9.5K	$0.39	$4K	SEC
2024-12-16	Charlton Ralph William III	CHIEF MEDICAL OFFICER	M — Option exercise	31.8K	$0.00	—	SEC
2024-12-16	Charlton Ralph William III	CHIEF MEDICAL OFFICER	F — Tax withholding / forfeiture	11.3K	$0.39	$4K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for SPRUCE BIOSCIENCES, INC. (SPRB). Updated in real time as new filings are submitted to the SEC.

Most-Active SPRB Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
SPIEGELMAN DANIEL K	1	—
GREY MICHAEL G	1	—
Barretto-Ko Percival	1	—
SIMPSON CAMILLA V	1	—
Szwarcberg Javier B.	1	$1K

Recent SPRB Form 8-K Material Events

2026-05-26 — Item 5.07, 9.01 [SEC]
2026-05-13 — Item 2.02, 9.01 [SEC]
2026-04-21 — Item 1.01, 8.01, 9.01 · Financing · neutral [SEC]
Spruce Biosciences entered into an underwriting agreement to issue 1,150,000 shares of common stock at $50.00 per share and 50,000 pre-funded warrants at $49.99 per warrant, with underwriters exercising their full 180,000 share option. The offering is expected to generate approxi
2026-03-20 — Item 1.02 · Contract · negative [SEC]
Spruce Biosciences terminated its collaboration and license agreement with Kaken Pharmaceutical for tildacerfont in Japan, effective March 31, 2026. The company will lose future milestone payments (up to $65 million) and royalties from the partnership, though it retains rights to
2026-03-09 — Item 1.01, 1.02, 2.02, 5.02, 9.01 · Financing · neutral [SEC]
Spruce Biosciences entered into a new Open Market Sale Agreement (ATM offering) with Jefferies LLC on March 9, 2026, replacing a prior agreement from February 2022. The company may offer and sell shares of common stock at-the-market through Jefferies, with Jefferies receiving up

Recent Insider Filings

2026-07-09 — Szwarcberg Javier B. (CHIEF EXECUTIVE OFFICER)
2026-05-26 — SPIEGELMAN DANIEL K (Insider)
2026-05-26 — SIMPSON CAMILLA V (Insider)
2026-05-26 — GREY MICHAEL G (Executive Chairman)
2026-05-26 — Barretto-Ko Percival (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SPRB insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SPRB Insider Trading — FAQ

What is the latest insider trade for SPRB?: SPRUCE BIOSCIENCES, INC. (SPRB) had 6 insider filings in the last 90 days, with the most recent on 2026-07-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SPRB stock?: 0 insider purchases of SPRB were filed in the last 90 days.
How many insiders are selling SPRB stock?: 0 insider sales of SPRB were filed in the last 90 days.
Where can I see SPRB SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SPRB SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live SPRB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.